GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity.

Autor: Watson DC; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.; Case Comprehensive Cancer Center, Cleveland, OH, USA.; University Hospitals Cleveland Medical Center, Cleveland, OH, USA.; School of Medicine, Case Western Reserve University, Cleveland, OH, USA.; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA., Bayik D; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.; Case Comprehensive Cancer Center, Cleveland, OH, USA.; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA., Storevik S; Department of Biomedicine, University of Bergen, Bergen, Norway.; Department of Neurology, Haukeland University Hospital, Bergen, Norway., Moreino SS; Department of Biomedicine, University of Bergen, Bergen, Norway., Sprowls SA; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Han J; Department of Biomedicine, University of Bergen, Bergen, Norway., Augustsson MT; Department of Biomedicine, University of Bergen, Bergen, Norway., Lauko A; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA.; Medical Scientist Training Program, Case Western Reserve University, Cleveland, OH, USA., Sravya P; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA., Røsland GV; Department of Biomedicine, University of Bergen, Bergen, Norway., Troike K; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Tronstad KJ; Department of Biomedicine, University of Bergen, Bergen, Norway., Wang S; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Sarnow K; Department of Biomedicine, University of Bergen, Bergen, Norway., Kay K; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Lunavat TR; Department of Biomedicine, University of Bergen, Bergen, Norway.; Department of Neurology, Molecular Neurogenetics Unit-West, Massachusetts General Hospital, Boston, MA, USA., Silver DJ; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Dayal S; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Joseph JV; Stipe Therapeutics, Aarhus, Denmark., Mulkearns-Hubert E; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA., Ystaas LAR; Department of Biomedicine, University of Bergen, Bergen, Norway., Deshpande G; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Guyon J; University of Bordeaux, INSERM, BRIC, Pessac, France., Zhou Y; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Magaut CR; University of Bordeaux, INSERM, BRIC, Pessac, France., Seder J; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Neises L; Cancer Metabolism Group, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg., Williford SE; University of Alabama at Birmingham, Birmingham, AL, USA., Meiser J; Cancer Metabolism Group, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg., Scott AJ; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA., Sajjakulnukit P; Cancer Biology Graduate Program, University of Michigan, Ann Arbor, MI, USA., Mears JA; Case Comprehensive Cancer Center, Cleveland, OH, USA.; School of Medicine, Case Western Reserve University, Cleveland, OH, USA., Bjerkvig R; Department of Biomedicine, University of Bergen, Bergen, Norway.; NorLux Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg., Chakraborty A; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.; Case Comprehensive Cancer Center, Cleveland, OH, USA., Daubon T; University of Bordeaux, CNRS, IBGC, Bordeaux, France., Cheng F; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.; Case Comprehensive Cancer Center, Cleveland, OH, USA., Lyssiotis CA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.; Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA., Wahl DR; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA., Hjelmeland AB; University of Alabama at Birmingham, Birmingham, AL, USA., Hossain JA; Department of Biomedicine, University of Bergen, Bergen, Norway., Miletic H; Department of Biomedicine, University of Bergen, Bergen, Norway. hrvoje.miletic@uib.no.; Department of Pathology, Haukeland University Hospital, Bergen, Norway. hrvoje.miletic@uib.no., Lathia JD; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. lathiaj@ccf.org.; Case Comprehensive Cancer Center, Cleveland, OH, USA. lathiaj@ccf.org.; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA. lathiaj@ccf.org.

Publikováno v: Nature cancer [Nat Cancer] 2023 May; Vol. 4 (5), pp. 648-664. Date of Electronic Publication: 2023 May 11.

A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1.

Autor: Libby CJ; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA., Gc S; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA., Benavides GA; Mitochondria Medicine Laboratory, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA., Fisher JL; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA., Williford SE; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA., Zhang S; Chemistry Department, Drug Discovery Division, Southern Research, Birmingham, AL, USA., Tran AN; Department of Neurosurgery, Northwestern University, Chicago, IL, USA., Gordon ER; HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA., Jones AB; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA., Tuy K; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA., Flavahan W; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worchester, MA, USA., Gordillo J; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA., Long A; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA., Cooper SJ; HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA., Lasseigne BN; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.; Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, AL, USA.; The Center for Clinical and Translational Science, University of Alabama at Birmingham, Birmingham, AL, USA.; UAB IMPACT Fund, University of Alabama at Birmingham, Birmingham, AL, USA., Augelli-Szafran CE; Chemistry Department, Drug Discovery Division, Southern Research, Birmingham, AL, USA., Darley-Usmar V; Mitochondria Medicine Laboratory, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA., Hjelmeland AB; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.

Publikováno v: Cell adhesion & migration [Cell Adh Migr] 2021 Dec; Vol. 15 (1), pp. 101-115.

Evolutionary pathways to NS5A inhibitor resistance in genotype 1 hepatitis C virus.

Autor: Zhou S; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: shuntaiz@email.unc.edu., Williford SE; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., McGivern DR; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Burch CL; Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Hu F; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China., Benzine T; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Ingravallo P; Infectious Diseases, Merck Research Laboratory, Kenilworth, NJ, USA., Asante-Appiah E; Infectious Diseases, Merck Research Laboratory, Kenilworth, NJ, USA., Howe AYM; Infectious Diseases, Merck Research Laboratory, Kenilworth, NJ, USA., Swanstrom R; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Lemon SM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: smlemon@med.unc.edu.

Publikováno v: Antiviral research [Antiviral Res] 2018 Oct; Vol. 158, pp. 45-51. Date of Electronic Publication: 2018 Aug 03.